Key result
Among 1,390 patients in New Zealand meeting criteria for advanced defibrillation strategies, the baseline survival to 30 days using standard defibrillation was 14%.
Why the study?
Does vector change or double sequential external defibrillation improve survival in patients with refractory ventricular fibrillation or pulseless ventricular tachycardia?
Does vector change or double sequential external defibrillation improve survival in patients with refractory ventricular fibrillation or pulseless ventricular tachycardia?
The implementation of vector change and double sequential external defibrillation for refractory VF/VT in New Zealand EMS affects approximately nine patients per week, providing a real-world opportunity to evaluate survival benefits.
Answers are grounded in this paper and cite their sources.
Highlights opportunity to assess advanced defibrillation in New Zealand EMS; leaves open whether vector change or double sequential strategies improve refractory VF/VT survival.
The New Zealand Medical Journal (NZMJ) is the principal scientific journal for the medical profession in New Zealand. The Journal has become a fundamental resource for providing research and written pieces from the health and medical industry.
No takes yet. Share an insight, caveat, or question.
Dicker et al. (2024) conducted a letter in Refractory ventricular fibrillation or pulseless ventricular tachycardia (n=1,390). Standard defibrillation was evaluated on Survival to 30 days. Among 1,390 patients in New Zealand meeting criteria for advanced defibrillation strategies, the baseline survival to 30 days using standard defibrillation was 14%.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: